184 related articles for article (PubMed ID: 27692662)
1. Place of non-vitamin K antagonist oral anticoagulants in anticoagulant-antiplatelet combinations in peripheral artery disease.
Stephan D; Cordeanu EM; Mirea C; Faller A; Lejay A; Gaertner S
Arch Cardiovasc Dis; 2016 Nov; 109(11):634-640. PubMed ID: 27692662
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
3. Individualized antithrombotic therapy.
Lüscher TF; Steffel J
Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
[TBL] [Abstract][Full Text] [Related]
4. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
Cairns JA; McMurtry MS
Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
[TBL] [Abstract][Full Text] [Related]
5. The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead.
Lucà F; Giubilato S; Fusco SAD; Leone A; Poli S; Rao CM; Iorio A; Gelsomino S; Gabrielli D; Colivicchi F; De Luca L; Gulizia MM
J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):391-398. PubMed ID: 32390532
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
Dewilde W; Berg JT
Am Heart J; 2009 Nov; 158(5):713-8. PubMed ID: 19853687
[TBL] [Abstract][Full Text] [Related]
7. Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?
Rossini R; Capodanno D; Ferrero P; Gargiulo G; Capranzano P
Int J Cardiol; 2016 Oct; 221():695-6. PubMed ID: 27423092
[No Abstract] [Full Text] [Related]
8. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
9. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY
Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulation alone or in combination with aspirin: risks and benefits.
Hafner J; de Moerloose P; Bounameaux H
Vasa; 1996; 25(1):1-12. PubMed ID: 8851260
[TBL] [Abstract][Full Text] [Related]
11. [How and when to use dual antiplatelet treatment in the patient treated with oral anticoagulants?].
Rubboli A; Di Pasquale G
G Ital Cardiol (Rome); 2008 Nov; 9(11):745-52. PubMed ID: 19058665
[TBL] [Abstract][Full Text] [Related]
12. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Rubboli A; Agewall S; Huber K; Lip GY
Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.
Paparella D; Di Mauro M; Bitton Worms K; Bolotin G; Russo C; Trunfio S; Scrofani R; Antona C; Actis Dato G; Casabona R; Colli A; Gerosa G; Renzulli A; Serraino F; Scrascia G; Zaccaria S; De Bonis M; Taramasso M; Delgado L; Tritto F; Marmo J; Parolari A; Myaseodova V; Villa E; Troise G; Nicolini F; Gherli T; Whitlock R; Conte M; Barili F; Gelsomino S; Lorusso R; Sciatti E; Marinelli D; Di Giammarco G; Calafiore AM; Sheikh A; Alfonso JJ; Glauber M; Miceli A;
J Thorac Cardiovasc Surg; 2016 May; 151(5):1302-8.e1. PubMed ID: 26832208
[TBL] [Abstract][Full Text] [Related]
14. The place of newer oral anticoagulants in the treatment of patients with non-valvular atrial fibrillation and coronary artery disease.
McCormack T
Int J Clin Pract; 2013 Aug; 67(8):707-9. PubMed ID: 23869674
[TBL] [Abstract][Full Text] [Related]
15. Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association.
Amara W; Larsen TB; Sciaraffia E; Hernández Madrid A; Chen J; Estner H; Todd D; Bongiorni MG; Potpara TS; Dagres N; Sagnol P; Blomstrom-Lundqvist C
Europace; 2016 Jan; 18(1):151-5. PubMed ID: 26462697
[TBL] [Abstract][Full Text] [Related]
16. Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence.
Dézsi CA; Dézsi BB; Dézsi AD
Eur J Gen Pract; 2017 Dec; 23(1):196-201. PubMed ID: 28743214
[TBL] [Abstract][Full Text] [Related]
17. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.
Pasceri V; Patti G; Pristipino C; Pelliccia F; Irini D; Varveri A; Roncella A; Di Sciascio G; Speciale G
Catheter Cardiovasc Interv; 2010 May; 75(6):936-42. PubMed ID: 20146326
[TBL] [Abstract][Full Text] [Related]
18. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
Gibson CM; Mehran R; Bode C; Halperin J; Verheugt F; Wildgoose P; van Eickels M; Lip GY; Cohen M; Husted S; Peterson E; Fox K
Am Heart J; 2015 Apr; 169(4):472-8.e5. PubMed ID: 25819853
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.
Fiedler KA; Byrne RA; Schulz S; Sibbing D; Mehilli J; Ibrahim T; Maeng M; Laugwitz KL; Kastrati A; Sarafoff N
Am Heart J; 2014 Apr; 167(4):459-465.e1. PubMed ID: 24655693
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotics in atrial fibrillation and coronary disease.
Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
